Skip to main content

Advertisement

Log in

Seizures in systemic sclerosis

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

The aim of this study was to evaluate the frequency of seizures in systemic sclerosis (SSc) and to determine the clinical and laboratory features associated with their occurrence. Thirty-four SSc patients (ACR criteria) were analyzed by a standard interview, physical examination, and review of medical charts. Risk factors for seizures, clinical manifestations, associated co-morbidities and current treatment were evaluated. We identified 3 (8.8 %) SSc patients with seizures. A higher median age [61 (35–64) vs. 48 (27–71) years, p = 0.0005] and higher activity score [4.75 (4.5–5.0) vs. 2.5 (0–5–5) years, p = 0.006] were observed in SSc patients with seizures. No other clinical or laboratory feature was associated with the occurrence of seizure in this cohort. This study demonstrated a higher prevalence of seizures in SSc when compared to general population. Seizures were associated with older age and higher activity score in this cohort.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Medsger TA Jr, Masi AT (1971) Epidemiology of systemic sclerosis (scleroderma). Ann Intern Med 74:714–721

    Article  PubMed  Google Scholar 

  2. Gordon RM, Silverstein A (1970) Neurologic manifestations in progressive systemic sclerosis. Arch Neurol 22:126–134

    Article  PubMed  CAS  Google Scholar 

  3. Hietaharju A, Jääskeläinen S, Kalimo H, Hietarinta M (1993) Peripheral neuromuscular manifestations in systemic sclerosis (scleroderma). Muscle Nerve 16:1204–1212

    Article  PubMed  CAS  Google Scholar 

  4. Mohamed RHA, Nassef AA (2010) Brain magnetic resonance imaging findings in patients with systemic sclerosis. Int J Rheum Dis 13:61–67

    Article  PubMed  Google Scholar 

  5. Mohammed RHA, Sabry YY, Nasef AA (2011) Brain MRI screening showing evidences of early central nervous system involvement in patients with systemic sclerosis. Rheumatol Int 31:667–671

    Article  PubMed  Google Scholar 

  6. Jimenez-Moreno J, Selva-O’Callaghan A, Rovira-Cañellas A, Solans-Laque R, Len O, Olias M, Fonollosa-Pla V, Vilardell-Tarres M (1998) Trigeminal sensory neuropathy in systemic sclerosis. Br J Rheumatol 37:587–589

    Article  PubMed  CAS  Google Scholar 

  7. Bondavalli P, Parodi A, Rebora A (1997) Peripheral neuropathy in scleroderma successfully treated with amitriptyline. Int J Dermatol 36:234–235

    Article  PubMed  CAS  Google Scholar 

  8. Allanore Y, Zuber M, Kahan A (2002) Brachial plexopathy associated with systemic sclerosis. Clin Rheumatol 21:401–402

    Article  PubMed  CAS  Google Scholar 

  9. Hietaharju A, Jääskeläinen S, Hietarinta M, Frey H (1993) Central nervous system involvement and psychiatric manifestations in systemic sclerosis (scleroderma): clinical and neurophysiological evaluation. Acta Neurol Scand 87:382–387

    PubMed  CAS  Google Scholar 

  10. Navon P, Halevi A, Brand A, Branski D, Rubinow A (1993) Progressive systemic sclerosis sine scleroderma in a child presenting as nocturnal seizures and Raynaud’s phenomenon. Acta Paediatr 82:122–123

    Article  PubMed  CAS  Google Scholar 

  11. Ishii A, Oguni E, Yoshizawa T, Mizusawa H, Muraki R (1993) A case of progressive systemic sclerosis with Sjögren’s syndrome presenting with coma, convulsion and bilateral thalamic hypodensity on computed tomography. Rinsho Shinkeigaku 33:966–970

    PubMed  CAS  Google Scholar 

  12. Uriuhara A, Morita S, Yamada K, Masugi J, Yamada H, Hasegawa Y, Yokono K, Kasuga M (1997) A case of MPO-ANCA positive progressive systemic sclerosis with status epileptics. Ryumachi 37:483–486

    PubMed  CAS  Google Scholar 

  13. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee Preliminary criteria for the classification of systemic sclerosis (scleroderma) (1980). Arthritis Rheum 23:581–590

    Google Scholar 

  14. LeRoy EC, Black C, Fleischmajer R et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205

    PubMed  CAS  Google Scholar 

  15. Furst DE, Clements PJ, Steen VD et al (1998) The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis. J Rheumatol 25:84–88

    PubMed  CAS  Google Scholar 

  16. Valentini G, Silman AJ, Veale D (2003) Assessment of disease activity. Clin Exp Rheumatol 21(3 Suppl 29):S39–S41

    PubMed  CAS  Google Scholar 

  17. Medsger TA Jr, Bombardieri S, Czirjak L, Scorza R, Della Rossa A, Bencivelli W (2003) Assessment of disease severity and prognosis. Clin Exp Rheumatol 21(3 Suppl 29):S42–S46

    PubMed  Google Scholar 

  18. Benseñor IM, Lotufo PA, Menezes PR, Scazufca M (2010) Subclinical hyperthyroidism and dementia: the São Paulo Ageing & Health Study (SPAH). BMC Public Health 10:298

    Article  PubMed  Google Scholar 

  19. Blume WT, Lüders HO, Mizrahi E, Tassinari C, van Emde Boas W, Engel J Jr (2001) Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology. Epilepsia 42:1212–1218

    Article  PubMed  CAS  Google Scholar 

  20. Fisher RS, van Emde Boas W, Blume W et al (2005) Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 46:470–472

    Article  PubMed  Google Scholar 

  21. Appenzeller S, Cendes F, Costallat LT (2004) Epileptic seizures in systemic lupus erythematosus. Neurology 63:1808–1812

    Article  PubMed  Google Scholar 

  22. Das CP, Prabhakar S, Lal V, Kharbanda PS (2002) Scleroderma, stroke, optic neuropathy: a rare association. Neurol India 50:504–507

    PubMed  CAS  Google Scholar 

  23. Clements PJ, Furst DE, Campion DS et al (1978) Muscle disease in progressive systemic sclerosis: diagnostic and therapeutic considerations. Arthritis Rheum 21:62–71

    Article  PubMed  CAS  Google Scholar 

  24. Averbuch-Heller Steiner I, Abramsky O (1992) Neurologic manifestation of progressive systemic sclerosis. Arch Neurol 49:1292–1295

    Article  PubMed  CAS  Google Scholar 

  25. Lucivero V, Mezzapesa DM, Petruzzellis M, Carella A, Lamberti P, Federico F (2004) Ischaemic stroke in progressive systemic sclerosis. Neurol Sci 25:230–233

    Article  PubMed  CAS  Google Scholar 

  26. Sardanelli F, Lozzelli A, Cotticelli B et al (2005) White matter hyperintensities on brain magnetic resonance in systemic sclerosis. Ann Rheum Dis 64:777–779

    Article  PubMed  CAS  Google Scholar 

  27. Pathak R, Gabor AJ (1991) Scleroderma and central nervous system vasculitis. Stroke 22:410–413

    Article  PubMed  CAS  Google Scholar 

  28. Fornes P, Chatellier J, Emmerich J et al (2002) Central nervous system involvement in scleroderma. Ann Med Interne 153:179–182

    Google Scholar 

  29. Andonopoulos AP, Maraziotis T, Yarmenitis S et al (1998) Multiple spontaneous intracerebral haemorrhage in a patient with progressive systemic sclerosis. Rev Rheum (ENGL ED) 65:437–440

    CAS  Google Scholar 

  30. Cutolo M, Nobili F, Sulli A et al (2000) Evidence of cerebral hypoperfusion in scleroderma patients. Rheumatology 39:1366–1373

    Article  PubMed  CAS  Google Scholar 

  31. Tuffanelli DL, Winkelmann RK (1961) Systemic scleroderma. Arch Dermatol 84:359–371

    Article  PubMed  CAS  Google Scholar 

  32. Forsgren L, Beghi E, Oun A, Sillanpää M (2005) The epidemiology of epilepsy in Europe - a systematic review. Eur J Neurol 12(4):245–253

    Article  PubMed  CAS  Google Scholar 

  33. Grosso S, Fioravanti A, Biasi G, Conversano E, Marcolongo R, Morgese G, Balestri P (2003) Linear scleroderma associated with progressive brain atrophy. Brain Dev 25:57–61

    Article  PubMed  Google Scholar 

  34. Kister I, Inglese M, Laxer R, Herbert J (2008) Neurologic manifestations of localized scleroderma. Neurology 71:1538–1545

    Article  PubMed  Google Scholar 

  35. Stone J, Franks AJ, Guthrie JA, Johnson MH (2001) Scleroderma ‘en coup de sabre’: pathological evidence of intracerebral inflammation. J Neurol Neurosurg Psychiatry 70:382–385

    Article  PubMed  CAS  Google Scholar 

  36. Menni S, Marzano AV, Passoni E (1997) Neurologic abnormalities in two patients with facial hemiatrophy and sclerosis coexisting with morphea. Pediatr Dermatol 14:113–116

    Article  PubMed  CAS  Google Scholar 

  37. Blaszczyk M, Jablonska S (1999) Linear scleroderma en Coup de Sabre: relationship with progressive facial hemiatrophy (PFH). Adv Exp Med Biol 455:101–104

    Article  PubMed  CAS  Google Scholar 

  38. Dupont S, Catala M, Hasboun D, Semah F, Baulac M (1997) Progressive facial hemiatrophy and epilepsy: a common underlying dysgenetic mechanism. Neurology 48:1013–1018

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

Carvalho JF received grants from Federico Foundation and CNPq (300665/2009-1); Apenzeller S received grants from CNPq (2009/06049-6) and FAPESP (2008/02917-0).

Conflict of interest

The authors declare no conflict of interests.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jozélio Freire de Carvalho.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Araújo, F.G., Amaral, T.N., Appenzeller, S. et al. Seizures in systemic sclerosis. Rheumatol Int 33, 1721–1724 (2013). https://doi.org/10.1007/s00296-012-2630-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-012-2630-y

Keywords

Navigation